Literature DB >> 17568691

Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin.

Rabab El Mezayen1, Mohamed El Gazzar, Michael C Seeds, Charles E McCall, Stephen C Dreskin, Mark R Nicolls.   

Abstract

Stressed cells undergoing necrosis release molecules that acts as endogenous danger signals to alert and activate innate immune cells. Both HMGB1 and HSP70 are induced in activated monocytes/macrophages and also are released from stressed or injured cells. We investigated whether HMGB1 and HSP70 released from necrotic monocytes/macrophages, can act as danger signals to mediate proinflammatory cytokine responses to bacterial endotoxin or lipopolysaccharide (LPS). We show that cell lysate, obtained from necrotic cells directly stimulates the proinflammatory cytokine and chemokine responses in human monocyte/macrophage cell line, THP-1, as revealed by the induction of TNF-alpha, IL-6 and IL-8 mRNA expression and protein production. In the presence of LPS, necrotic cell lysate induced a more robust increase in all three proteins. We found that HMGB1 and HSP70 were indeed present in the necrotic cell lysate and were responsible for the significant induction of the proinflammatory cytokine expression, as neutralization with antibodies against both proteins blocked the increase in the cytokine production seen after incubating LPS-stimulated cells with the necrotic cell lysate. We also found that the newly identified triggering receptor expressed on myeloid cells-1 (TREM-1) was involved in mediating the HMGB1- and HSP70-induced cytokine production. Blocking TREM-1 on THP-1 cells with a recombinant chimera prevented the increase in cytokine production, while simultaneous blocking of TLR4 and TREM-1 completely abolished the proinflammatory response, suggesting that TREM-1 synergizes with TLR4 to mediate the effects of such signals from necrotic cells. In addition, blocking HMGB1 or HSP70 simultaneously with TREM-1 did not decrease the cytokine level further, confirming the involvement of TREM-1 in mediating the effect of HMGB1 and HSP70. Although the interaction of HMGB1 and HSP70 with TREM-1 induced I kappa B alpha and p38 expression, both of which are required for the inflammatory cytokine expression, blockade of TREM-1 did not affect I kappa B alpha expression but markedly reduced p38 activation, as revealed by Western blot analysis. Together, these results demonstrate that HMGB1 and HSP70 released from necrotic cells function as endogenous danger signals to augment the proinflammatory responses in monocytes/macrophage and that TREM-1 relays such signals to the cytokine expression cascade. This mechanism may contribute to the amplification and persistence of the inflammatory response to bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568691      PMCID: PMC3034364          DOI: 10.1016/j.imlet.2007.04.011

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  43 in total

Review 1.  Overview of vaccine adjuvants: present and future.

Authors:  Robert L Hunter
Journal:  Vaccine       Date:  2002-05-31       Impact factor: 3.641

Review 2.  TREMs in the immune system and beyond.

Authors:  Marco Colonna
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

Review 3.  Recognition of microbial infection by Toll-like receptors.

Authors:  Elizabeth Kopp; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

Review 4.  Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.

Authors:  Mihai G Netea; Chantal van der Graaf; Jos W M Van der Meer; Bart Jan Kullberg
Journal:  J Leukoc Biol       Date:  2004-01-14       Impact factor: 4.962

5.  Activation of gene expression in human neutrophils by high mobility group box 1 protein.

Authors:  Jong Sung Park; John Arcaroli; Ho-Kee Yum; Huan Yang; Haichao Wang; Kuang-Yao Yang; Kang-Hyeon Choe; Derek Strassheim; Todd M Pitts; Kevin J Tracey; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2003-04       Impact factor: 4.249

6.  A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.

Authors:  Joshua R Bleharski; Viviane Kiessler; Cecilia Buonsanti; Peter A Sieling; Steffen Stenger; Marco Colonna; Robert L Modlin
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  High mobility group 1 B-box mediates activation of human endothelium.

Authors:  C J Treutiger; G E Mullins; A-S M Johansson; A Rouhiainen; H M E Rauvala; H Erlandsson-Harris; U Andersson; H Yang; K J Tracey; J Andersson; J E W Palmblad
Journal:  J Intern Med       Date:  2003-10       Impact factor: 8.989

8.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

9.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

10.  Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system.

Authors:  Jay Campisi; Ted H Leem; Monika Fleshner
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

View more
  71 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

3.  Dear SIRS, the concept of "alarmins" makes a lot of sense!

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

4.  High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.

Authors:  Magda Suchankova; Vladimira Durmanova; Elena Tibenska; Eva Tedlova; Ivan Majer; Helena Novosadova; Juraj Demian; Miroslav Tedla; Maria Bucova
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 5.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

6.  Pediatric Sepsis - Part V: Extracellular Heat Shock Proteins: Alarmins for the Host Immune System.

Authors:  John S Giuliano; Patrick M Lahni; Hector R Wong; Derek S Wheeler
Journal:  Open Inflamm J       Date:  2011-10-07

Review 7.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

Review 8.  Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects.

Authors:  Petrus R de Jong; Alvin W L Schadenberg; Nicolaas J G Jansen; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2008-07-31       Impact factor: 3.667

Review 9.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

Review 10.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.